Hematologic Cancer Clinical Trials

Duarte : City of Hope

A Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Efficacy and Safety of Two Different Doses of Palonosetron Compared to Ondansetron in the Prevention of CINV in Pediatric Patients Undergoing Single and Repeated Cycles of MEC or HEC

Duarte : City of Hope

A Pilot Study to Evaluate the Co-infusion of Ex Vivo Expanded Umbilical Cord Blood Progenitors with an Unmanipulated Cord Blood Graft in Patients Undergoing Umbilical Cord Blood Transplantation for Hematologic Malignancies

Duarte : City of Hope

A Randomized, Multicenter, Single Blinded, Parallel Study of the Safety of 100 mg and 200 mg Oseltamivir Administered Intraveneously for the Treatment of Influenza in Patients Aged >/=13 Years

Duarte : City of Hope

A Randomized, Placebo-Controlled,Multi-Site Phase 2 Study Evaluating the Safety and Efficacy of Preemptive Treatment with CMX001 for the Prevention of Adenovirus Disease Following Hematopoeitic Stem Cell Transplantation (The ADV HALT Trial)

Duarte : City of Hope

CIBMTR 10-CBA: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adults Patients with Hematologic Malignancies and Other Indications

Duarte : City of Hope

COG ALTE03N1: Key Adverse Events After Childhood Cancer

Duarte : City of Hope

Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients

Duarte : City of Hope

Defibrotide for Patients with Hepatic Veno-Occlusive Disease (VOD): A Treatment IND Study(Under CFR 312.34)

Duarte : City of Hope

Long Term Follow-up Clinic for Survivors of Childhood Cancer

Duarte : City of Hope

NMDP 2002-0063: Research Database for Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries

Fort Lauderdale : Holy Cross Hospital

CA209-309

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy

Morgantown : West Virginia University - Clinical Trials Research Unit

001-01 - A Phase III, Double- Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trail to Study the Safety, Tolerability, Efficacy and Immunogenicity of V212 in Recipients of Autologous Hematopoietic Cell Transplants (HCTs)

Morgantown : West Virginia University - Clinical Trials Research Unit

E2905 - Randomized Phase III Trial Comparing the frequency of Major Erythroid Response to Treatment with Lenolidomide Alone and in Combination with Epoetin Alfa in Subjects with Low or Intermediate 1 Risk MDS and Symptomatic Anemia